Sjogren’s Syndrome Stem Cell Treatment in Delhi, India

Sjogren's syndrome is a chronic autoimmune disorder in which the immune system turns against the body's own moisture-producing glands, primarily leading to dryness and irritation of the eyes and mouth. Over time, other organs such as the joints, lungs, kidneys, and nerves may also become involved. Because early symptoms are easy to overlook, diagnosis is often delayed.

Stem cell therapy for Sjogren's syndrome in India is being explored as a supportive option for patients seeking additional care alongside standard rheumatology management, with the aim of improving day-to-day comfort and quality of life.

The condition is most often seen in middle-aged women, though it can affect anyone. It may occur as a standalone (primary) condition, or alongside another autoimmune disease (secondary), and it tends to progress slowly, which is part of why early awareness and evaluation matter.

Left unaddressed, Sjogren's syndrome can contribute to dental disease, eye complications, respiratory infections, and, in some cases, broader tissue involvement, along with persistent fatigue that can affect quality of life. Because it is an autoimmune condition, management can be complex, which is why research into supportive regenerative approaches continues.

Symptoms of Sjogren's syndrome tend to develop gradually and vary in intensity from person to person, most commonly centering on dryness and fatigue.

• Dry Eyes: A persistent gritty, burning sensation, along with redness and light sensitivity.
• Dry Mouth: A sticky, dry feeling that can make chewing, swallowing, and speaking difficult.
• Swollen Salivary Glands: Noticeable swelling near the ears and jaw.
• Fatigue: Persistent tiredness that does not fully resolve with rest.
• Joint Pain and Stiffness: Discomfort that may be more pronounced in the morning or after inactivity.
• Dry Skin: Rough, itchy, or flaking skin due to reduced moisture.
• Dryness in Other Areas: The throat, nose, and internal tissues may also be affected, sometimes with a dry cough.
• Dental Problems: Reduced saliva increases the risk of cavities, gum disease, and oral infections.

Sjogren's syndrome can present in several forms depending on how it develops and which parts of the body it affects. Recognizing these distinctions helps guide a more tailored approach to care.

• Primary Sjogren's Syndrome: Occurs on its own, without another underlying autoimmune disease, and primarily targets the tear and salivary glands.
• Secondary Sjogren's Syndrome: Develops alongside another autoimmune condition, most often rheumatoid arthritis or lupus, with additional symptoms related to the accompanying disease.
• Early-Onset Sjogren's Syndrome: Symptoms begin at a younger age, often mildly at first, with gradual progression if not identified early.
• Late-Onset Sjogren's Syndrome: Develops after age 50 and may be more noticeable, sometimes alongside other age-related health conditions.
• Systemic Sjogren's Syndrome: Extends beyond the glands to involve organs such as the lungs, kidneys, or nervous system, requiring closer monitoring.
• Localized Sjogren's Syndrome: Remains confined to specific areas, most commonly the eyes or mouth.

Sjogren's syndrome results from a combination of factors rather than a single cause, centered on an immune system that becomes overactive and begins targeting the body's own moisture-producing tissue.

• Autoimmune Reaction: An abnormal immune response that targets the salivary and tear glands.
• Genetic Factors: A family history of autoimmune disease can raise susceptibility.
• Hormonal Influence: The condition is more common in women, and hormonal shifts, particularly in middle age, may play a role.
• Viral Infections: Certain viral infections may trigger an ongoing immune response even after the virus clears.
• Environmental Factors: Exposure to pollutants or environmental toxins may contribute in susceptible individuals.
• Other Autoimmune Diseases: Conditions such as rheumatoid arthritis and lupus are commonly seen alongside Sjogren's syndrome.
• Age Factor: The condition most often appears after age 40, as immune function changes with age.
• Immune System Dysfunction: Ongoing immune dysregulation can drive persistent gland inflammation.

Because its symptoms overlap with other conditions, Sjogren's syndrome is diagnosed using a combination of history, examination, and targeted testing.

• Medical History and Symptom Review: A detailed discussion of dryness, fatigue, and joint symptoms, including their duration and severity.
• Physical Examination: Checking for gland swelling, dry skin, and dryness of the eyes and mouth.
• Schirmer's Test: Measures tear production using a small paper strip placed under the eyelid.
• Blood Tests: Checks for specific antibodies such as ANA, anti-SSA (Ro), and anti-SSB (La), and signs of immune overactivity.
• Salivary Gland Tests: Assess saliva production and gland function.
• Lip Biopsy: A small tissue sample from the inner lip examined for gland inflammation.
• Imaging Tests: Ultrasound or MRI to assess gland structure and detect changes.

Stem cell therapy is being researched as a way to help regulate the immune response and support tissue repair in patients with Sjogren's syndrome. Stem cells have the capacity to support the repair of a range of tissue types and are being studied for potential applications across autoimmune, joint, and other conditions.

Stem cell therapy for Sjogren's syndrome centers on helping to calm inflammation in the affected glands, supporting the healing of damaged tissue, and improving the production of tears and saliva. It is generally offered as a complement to ongoing rheumatology care, not a replacement for it.

Role of Stem Cells in Supporting Gland Function

• May help regulate the immune system and reduce its overactivity
• May help reduce inflammation in glands and surrounding tissue
• Supports repair of damaged salivary and tear glands
• May improve moisture production in the eyes and mouth
• May help slow disease progression
• Contributes to overall healing and patient wellbeing

Stem cell therapy for Sjogren's syndrome follows a general sequence: cells are collected and processed under controlled laboratory conditions, then administered into the body, most often intravenously.

• Collection and Preparation: Stem cells are sourced from reliable origins such as bone marrow or umbilical cord tissue and processed in a controlled lab environment.
• Administration into the Body: Processed cells are introduced through intravenous infusion, allowing them to circulate throughout the body.
• Targeting the Affected Glands: Cells are drawn toward inflamed salivary and tear glands in response to signals released by damaged tissue.
• Immune System Regulation: Stem cells help moderate abnormal immune activity directed at gland tissue.
• Reducing Inflammation and Damage: Anti-inflammatory signaling released by the cells may help calm irritated tissue.
• Tissue Repair and Long-Term Support: Ongoing support for gland repair and moisture production over time.

Stem cell therapy for Sjogren's syndrome in India generally follows a structured three-day plan to ensure proper evaluation, a safe procedure, and adequate monitoring.

Day 1: Evaluation and Preparation

• Airport pickup and transfer to the hospital
• Detailed consultation with the medical team to review goals and answer questions
• Hospital admission formalities
• Pre-treatment blood work and immune system-related investigations
• Supportive therapy as advised ahead of the procedure

Day 2: Stem Cell Therapy Procedure

• Stem cell administration under medical supervision
• Close observation during and after the procedure
• Continued supportive therapy as recommended
• Physiotherapy or wellness sessions where appropriate

Day 3: Monitoring and Discharge

• Final evaluation of the patient's condition
• Discharge formalities
• Transfer back to the airport

Note: Please bring a valid photo ID and hard copies of any existing medical reports at the time of admission.

Depending on the patient's condition and evaluation, stem cells for Sjogren's syndrome are typically administered through intravenous infusion, allowing the cells to circulate systemically and reach affected gland tissue in response to signals released from areas of inflammation.

Stem cell therapy is intended to support the body's own healing processes, particularly relevant for long-term autoimmune conditions. Patients have reported a range of improvements over time.

• Improved Moisture Production: Gradual improvement in saliva and tear production, reducing dryness in the mouth and eyes.
• Reduced Inflammation: Better immune regulation may help lower inflammation and associated discomfort.
• Improved Immune Balance: Supports a more regulated immune response, reducing activity directed against the body's own tissue.
• Increased Energy Levels: Many patients report reduced fatigue as inflammation eases.
• Relief from Joint and Muscle Discomfort: Easier movement and reduced stiffness for some patients.
• Improved Organ Function: Potential support for organs affected by systemic involvement.
• Improved Quality of Life: Fewer and less disruptive symptoms can make daily activities more manageable.

Stem cell therapy for Sjogren’s Syndrome is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Sjogren’s Syndrome, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

A supportive-care discussion for Sjogren’s Syndrome isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Sjogren’s Syndrome are reviewed by the medical team first.
2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
5. Ongoing standard care continues: At every stage, your prescribed treatment for Sjogren’s Syndrome continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

Stem Cell Care India has built its reputation on providing accessible, closely supervised regenerative therapies to patients from around the world. We understand the daily impact of living with chronic dryness and discomfort, and we are committed to offering safe, advanced, and compassionate care.

Our team remains available throughout the recovery period so that patients always have somewhere to turn with questions or concerns, and every case is treated with the individual attention it deserves. We follow strict, internationally recognized safety and quality standards throughout every stage of treatment.

Stem cell therapy pricing can vary considerably depending on individual circumstances. India's competitive medical tourism industry allows Stem Cell Care India to offer this therapy at a fraction of the cost typically seen in Western countries, without compromising on quality or safety.

Factors that can influence the overall cost of stem cell treatment for Sjogren's syndrome include:

• The extent and severity of the patient's symptoms
• The number of therapy sessions recommended
• The source and quantity of stem cells required
• Pre-treatment diagnostic tests and evaluations
• The length of hospital stay and monitoring required

Patients seeking a personalized cost estimate are encouraged to schedule a free consultation with our team.

Outcomes for regenerative approaches to Sjogren's syndrome remain an evolving area of research, and results can vary considerably depending on the stage of disease and individual patient factors.

• Patient's Overall Health: General health and immune status influence how the body responds to therapy.
• Stage of the Condition: Earlier intervention is generally associated with a greater chance of improvement.
• Quality of Stem Cells Used: Cells are tested for safety and effectiveness before use.
• Personalized Treatment Planning: Protocols are tailored to each patient's specific condition.
• Lifestyle and Habits: Adequate hydration, nutrition, and a healthy lifestyle support better outcomes.
• Follow-Up Care: Regular monitoring allows the team to track and adjust therapy as needed.

Stem cell therapy offers a supportive avenue for patients seeking additional options for managing Sjogren's syndrome, alongside standard rheumatology care.

• International Patient Facility: Complete assistance for a hassle-free experience abroad.
• Domestic Patient Facility: Easy access, scheduling, and support for local patients.
• Round-the-Clock Patient Care: Continuous attention throughout the course of therapy.
• Nutritional Counseling: Guidance on a healthy diet supportive of immune balance.
• Travel Support: Assistance with travel and accommodation arrangements.
• Personalized Planning: Treatment plans built around individual medical history and needs.

Maintaining high standards of quality is central to safe and effective treatment. Stem Cell Care India follows a carefully monitored process at every stage.

• Strict Donor Screening: Thorough testing to check the quality of stem cells and rule out infection risk.
• Advanced Laboratory Processing: Procedures conducted in accordance with international safety and hygiene standards.
• Quality and Strength Testing: Cells are evaluated before use to confirm only high-quality cells are administered.
• Repeated Sterility Checks: Screening for bacteria, viruses, or other contaminants.
• Proper Storage and Transportation: Cells are maintained at the correct temperature to preserve efficacy.
• Patient Monitoring: Continuous monitoring and documentation by the medical team.

Outcomes can vary from patient to patient, but many who combine therapy with consistent follow-up care report meaningful improvement.

• Improved moisture production in the eyes and mouth
• Better immune system regulation
• Reduced inflammation and associated discomfort
• Enhanced energy levels
• Support for tissue repair in salivary and tear glands
• Improved overall quality of life

Patients tend to notice changes within a few weeks to months, with supportive care and monitoring helping to sustain results over time.

Li Wei, China: I had been struggling with constant dryness in my eyes and mouth for years. After treatment, I noticed gradual improvement in my symptoms and energy levels, and the medical team was supportive throughout.

Siti Rahmawati, Indonesia: My Sjogren's symptoms were affecting my daily life. After treatment, I began to feel steady relief in dryness and fatigue, and the doctors explained everything clearly.

Rami Haddad, Lebanon: After undergoing stem cell therapy, I noticed gradual relief in dryness and joint discomfort. The team provided excellent care and support during my stay.

A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.

The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Sjogren’s Syndrome, and a supporting team of medical staff is described as being available throughout the process.

Stem Cell Care India's medical team stays connected with patients after treatment, monitoring symptoms such as dry mouth, dry eyes, and fatigue, and providing guidance on diet, lifestyle, and simple exercises to support recovery. Regular follow-up allows for early detection of any concerns and helps patients get the maximum benefit from therapy.

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for sjogren’s syndrome include:

• Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a sjogren’s syndrome.
• Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
• Physiotherapy: To help rebuild movement, balance, and muscle strength.
• Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
• Acupuncture: Used by some patients as a complementary approach alongside conventional care.
• Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
• Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
• Nutrition therapy: Dietary guidance intended to support general recovery.
• Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

Sjogren's syndrome affects people everywhere, but access to advanced regenerative options can vary significantly by country. For many international patients, high costs, limited availability, or stricter regulatory pathways at home make it difficult to explore stem cell-based approaches for this condition.

Stem cell therapy for Sjogren's syndrome is offered as an alternative wellness pathway focused on immune regulation, reduced inflammation, and improved gland function. By combining advanced facilities with more accessible pricing, India has become a meaningful option for patients seeking this kind of supportive care from abroad.

Medical Facilities That Make India Famous Among International Patients

India has become a leading destination for international patients exploring stem cell therapy for Sjogren's syndrome, supported by hospitals that combine strong infrastructure, experienced medical teams, and patient-centered services. Facilities available to international patients typically include:

• Dedicated Stem Cell Therapy Centers: Purpose-built departments equipped with modern regenerative technology.
• Experienced Medical Teams: Physicians and scientists who tailor each protocol to the individual patient.
• Advanced Diagnostic Facilities: On-site laboratories and imaging services for accurate evaluation.
• Multilingual Support: Interpreters and coordinators bridging communication for international patients.
• Personalized Treatment Plans: Protocols built around each patient's goals and health history.
• Affordable Treatment Packages: Costs considerably lower than comparable options in many Western countries.
• International Patient Support: Dedicated coordinators for medical visas, travel, and logistics.
• Comfortable Accommodation: Hospital suites, guest houses, or partner hotel arrangements.
• Post-Treatment Support: Physiotherapy and wellness programs to help sustain results.
• Round-the-Clock Medical Support: Continuous clinical availability throughout a patient's stay.

• Allogeneic Mesenchymal Stem Cell Treatment Alleviates Experimental and Clinical Sjögren Syndrome — Xu J, Wang D, Liu D, et al., Blood
• Mesenchymal Stem Cell Transplantation Alleviates Experimental Sjögren's Syndrome Through IFN-β/IL-27 Signaling Axis — Yao G, Qi J, Liang J, et al., Theranostics
• Mesenchymal Stem Cells Extract-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjögren's Syndrome-Like Disease — Abughanam G, Elkashty OA, Liu Y, et al., International Journal of Molecular Sciences
• Stem Cells From Exfoliated Deciduous Teeth Alleviate Hyposalivation Caused by Sjögren Syndrome — Du ZH, Ding C, Zhang Q, et al., Oral Diseases
• Allogeneic Mesenchymal Stem Cell Therapy for Dry Eye Disease in Patients With Sjögren's Syndrome: A Randomized Clinical Trial — Møller-Hansen M, Larsen AC, Wiencke AK, et al., The Ocular Surface

Sjogren's syndrome is a chronic autoimmune condition that, if left unaddressed, can meaningfully affect a person's daily comfort and quality of life. Understanding its causes, symptoms, and types supports earlier diagnosis and more effective long-term management.

Regular medical monitoring and supportive lifestyle habits remain the foundation of managing this condition. Stem cell-based supportive care offers an additional approach that may help regulate immune activity and support gland function, working alongside, rather than in place of, standard rheumatology care.

As with any regenerative approach, outcomes vary from patient to patient. When combined with consistent medical care, stem cell-based supportive care may offer a meaningful, evidence-informed option for patients working toward better long-term comfort and health.

Treatment Disclaimer: We provide consultation, case evaluation, and patient support services in the field of regenerative medicine. As per current medical guidelines in India, stem cell-based interventions (other than approved indications) are considered investigational and are available only within regulated clinical research settings. For patients exploring broader options, we also assist in facilitating access to treatment pathways, including internationally accredited centers where different regulatory frameworks may apply.